Volitionrx (VNRX) Return on Capital Employed (2013 - 2025)
Volitionrx (VNRX) posted Return on Capital Employed of 391.29% for Q4 2025, down 33.72% on a QoQ basis from 590.4% in Q3 2025, and up 122305.0% year-over-year from N/an in Q4 2024.
Volitionrx (VNRX) Return on Capital Employed (2013 - 2025) Analysis & Trends
Volitionrx's Return on Capital Employed history runs 8 years deep, the most recent figure standing at 391.29% for Q4 2025.
- Quarterly Return on Capital Employed rose 122305.0% year-over-year to 391.29% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 391.29% (up 122305.0% YoY) and the FY2025 annual result came in at 532.76%, up 78105.0% from the prior year.
- Return on Capital Employed was 391.29% for Q4 2025 at Volitionrx, down from 590.4% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 3734.49% in Q2 2025 and bottomed at 3559.03% in Q1 2023.
- A 5-year average of 351.25% and a median of 251.97% in 2022 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2024 — Return on Capital Employed surged 401196 bps — and 2025, when it slumped 397157 bps.
- Volitionrx's Return on Capital Employed stood at 127.45% in 2021, then slumped by 627 bps to 925.96% in 2022, then surged by 72 bps to 256.1% in 2023, then tumbled by 225 bps to 831.76% in 2024, then jumped by 147 bps to 391.29% in 2025.
- Business Quant data shows VNRX's Return on Capital Employed at 391.29% in Q4 2025, 590.4% in Q3 2025, and 3734.49% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Volitionrx | 109,643.10 | -2.35 Mn | - | 391.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 391.29% |
| Sep 30, 2025 | 590.40% |
| Jun 30, 2025 | 3,734.49% |
| Mar 31, 2025 | -3,518.64% |
| Dec 31, 2024 | -831.76% |
| Sep 30, 2024 | 172.27% |
| Jun 30, 2024 | 222.55% |
| Mar 31, 2024 | 452.93% |
| Dec 31, 2023 | -256.10% |
| Sep 30, 2023 | -685.05% |
| Jun 30, 2023 | -865.02% |
| Mar 31, 2023 | -3,559.03% |
| Dec 31, 2022 | -925.96% |
| Sep 30, 2022 | -474.13% |
| Jun 30, 2022 | -301.22% |
| Mar 31, 2022 | -247.84% |
| Dec 31, 2021 | -127.45% |
| Sep 30, 2021 | -94.16% |
| Mar 31, 2020 | -123.87% |
| Dec 31, 2019 | -85.75% |